Pegloticase Long-Term Safety: Data From the Open-Label Extension Trial.

被引：0

作者：

Becker, Michael A. ^{[1
]}

Baraf, Herbert S. B. ^{[2
]}

Yood, Robert A. ^{[3
]}

Dillon, Aileen M. ^{[4
]}

Vazquez-Mellado, Janitzia ^{[5
]}

Ottery, Faith D. ^{[6
]}

Khanna, Dinesh ^{[7
]}

Sundy, John S. ^{[8
]}

机构：

[1] Univ Chicago, Chicago, IL 60637 USA

[2] Arthrit Rheumatism Associates, Wheaton, MD USA

[3] Reliant Med Grp, Worcester, MA USA

[4] Kaiser Fdn Hosp, San Francisco, CA USA

[5] Hosp Gen Mexico City, Mexico City, DF, Mexico

[6] Savient Pharmaceut Inc, E Brunswick, NJ USA

[7] Univ Michigan, Ann Arbor, MI 48109 USA

[8] Duke Univ, Med Ctr, Durham, NC USA

来源：

ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

160

引用

页码：S69 / S70

页数：2

共 50 条

[21] Long-term safety of brodalumab in Japanese patients with plaque psoriasis: An open-label extension study
Yamaguchi, Yukie
Takatsu, Nobumichi
Ootaki, Kenji
Nakagawa, Hidemi
JOURNAL OF DERMATOLOGY, 2020, 47 (06): : 569 - 577
[22] Sparsentan for Focal Segmental Glomerulosclerosis in the DUET Open-Label Extension: Long-term Efficacy and Safety
Campbell, Kirk N.
Gesualdo, Loreto
Murphy, Edward
Rheault, Michelle N.
Srivastava, Tarak
Tesar, Vladimir
Komers, Radko
Trachtman, Howard
KIDNEY MEDICINE, 2024, 6 (06)
[23] Long-Term Efficacy and Safety of Etrasimod for Ulcerative Colitis: Results From the Open-Label Extension of the OASIS Study
Chiorean, Michael
Vermeire, Severine
Panes, Julian
Peyrin-Biroulet, Laurent
Zhang, Jinkun
Sands, Bruce E.
Lazin, Krisztina
Cabell, Chris H.
Naik, Snehal U.
Klassen, Preston
Sandborn, William J.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S445 - S446
[24] Long-term Efficacy and Safety From an Open-Label Extension of Adjunctive Cenobamate in Patients With Uncontrolled Focal Seizures
Klein, Pavel
Aboumatar, Sami
Brandt, Christian
Dong, Fang
Krauss, Gregory L.
Mizne, Sarah
Sanchez-Alvarez, Juan Carlos
Steinhoff, Bernhard J.
Villanueva, Vicente
NEUROLOGY, 2022, 99 (10) : E989 - E998
[25] Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study
Vermeire, Severine
Chiorean, Michael
Panes, Julian
Peyrin-Biroulet, Laurent
Zhang, Jinkun
Sands, Bruce E.
Lazin, Krisztina
Klassen, Preston
Naik, Snehal U.
Cabell, Christopher H.
Sandborn, William J.
JOURNAL OF CROHNS & COLITIS, 2021, 15 (06): : 950 - 959
[26] Fluoxetine for the treatment of childhood anxiety disorders: Open-label, long-term extension to a controlled trial
Clark, DB
Birmaher, B
Axelson, D
Monk, K
Kalas, C
Ehmann, M
Bridge, J
Wood, DS
Muthen, B
Brent, D
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2005, 44 (12): : 1263 - 1270
[27] An open-label, long-term, phase III extension trial of duloxetine in Japanese patients with fibromyalgia
Murakami, Masato
Osada, Kenichi
Ichibayashi, Hisao
Mizuno, Hiromichi
Ochiai, Toshimitsu
Ishida, Mitsuhiro
Alev, Levent
Nishioka, Kusuki
MODERN RHEUMATOLOGY, 2017, 27 (04) : 688 - 695
[28] Long-term treatment with lasmiditan in patients with migraine: Results from the open-label extension of the CENTURION randomized trial
Ashina, Messoud
Roos, Caroline
Li, Lily Qian
Komori, Mika
Ayer, David
Ruff, Dustin
Krege, John Henry
CEPHALALGIA, 2023, 43 (04)
[29] Safety of upadacitinib in ulcerative colitis: Long-term data from the phase 3 open-label extension study (U-ACTIVATE)
Panaccione, R.
Lichtenstein, G.
Nakase, H.
Armuzzi, A.
Kucharzik, T.
Levy, G.
Palac, H.
Kujawski, M.
Klaff, J.
Cheon, J. H.
JOURNAL OF CROHNS & COLITIS, 2023, 17 : 644 - 646
[30] SAFETY OF UPADACITINIB IN ULCERATIVE COLITIS: LONG-TERM DATA FROM THE PHASE 3 OPEN-LABEL EXTENSION STUDY (U-ACTIVATE)
Panaccione, Remo
Lichtenstein, Gary R.
Nakase, Hiroshi
Armuzzi, Alessandro
Kucharzik, Torsten
Levy, Gweneth
Palac, Hannah
Kujawski, Michelle
Klaff, Justin
Cheon, Jae Hee
GASTROENTEROLOGY, 2023, 164 (06) : S1100 - S1100

← 1 2 3 4 5 →